RACC — Research Alliance Corp III
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2118032 ·
Last close
$10.71
Market Cap
$83.27M
52W High
$33.50
52W Low
$9.62
ADV30
116,149
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -184,418 | 54,050 | 76,307,137 | 832,812 | 2,305,587 |
| Mar 2026 | 0 | — | -65,249 | -65,249 | 732,917 | 280,275 | 773,166 |
| Feb 2026 | — | — | — | — | 128,033 | — | 136,730 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,600
Investing CF
—
Financing CF
$282,875
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.01
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-65,249
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-65,249
Pretax Income TTM
$-65,249
Interest Exp TTM
—
Analysts
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TELO | Telomir Pharmaceuticals, Inc. | $82.53M | $1.20 | — |
| ONCY | ONCOLYTICS BIOTECH INC | $84.54M | $0.66 | — |
| RVRC | Revium Rx. | $86.84M | $1.43 | — |
| PRNAF | ALTERITY THERAPEUTICS LTD | $87.40M | $0.40 | — |
| VRCA | Verrica Pharmaceuticals Inc. | $79.02M | $4.60 | — |
News headlines (Yahoo Finance, 1h cache)
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rug
2026-07-27 12:00 · Yahoo
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING
2026-05-20 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.